Savvy Advisors Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79M Buy
62,527
+5,357
+9% +$312K 0.1% 156
2025
Q4
$3.08M Buy
57,170
+9,893
+21% +$476K 0.1% 148
2025
Q3
$2.13M Buy
47,277
+867
+2% +$40.5K 0.1% 145
2025
Q2
$2.15M Buy
46,410
+18,835
+68% +$925K 0.14% 110
2025
Q1
$1.68M Buy
27,575
+1,645
+6% +$95.9K 0.17% 98
2024
Q4
$1.47M Buy
25,930
+21,107
+438% +$1.18M 0.18% 100
2024
Q3
$250K Buy
+4,823
New +$226K 0.05% 293

Other funds holding BMY

Savvy Advisors Inc's BMY Position: Q1 2026 in Review

Savvy Advisors Inc increased its Bristol-Myers Squibb (BMY) stake by 9.4% in Q1 2026, buying an estimated $312K and bringing the position to 62,527 shares worth $3.79M. The position accounts for 0.1% of the portfolio, ranked #156.

Savvy Advisors Inc first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Savvy Advisors Inc held 62,527 shares of Bristol-Myers Squibb worth $3.79M as of Q1 2026.
  • Savvy Advisors Inc bought 5,357 Bristol-Myers Squibb shares in Q1 2026, an estimated $312K.
  • Bristol-Myers Squibb made up 0.1% of Savvy Advisors Inc's portfolio in Q1 2026, its #156 holding.
  • Savvy Advisors Inc first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.